JNJ
Johnson & Johnson·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 4
Dividend Aristocrat
MACD Death Cross
High Gross Profit Margin
Gap Down
High Cash/net Profit Ratio
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About JNJ
Johnson & Johnson
The world's largest, most diversified healthcare products company
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933
R & D, manufacture and sale of healthcare products
Johnson & Johnson was incorporated in New Jersey in 1887. Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacturing and sales of various products in the healthcare field. Johnson & Johnson is a holding company with operating companies in almost all countries around the world. The company's main focus is on products related to human health and well-being. The company is divided into two business divisions: innovative medicine and medical technology.
Earnings Call
Q2/2025
Estimate EPS2.68
Actual EPS2.77
Estimate Revenue22.86B
Actual Revenue23.74B
Contradictions Unveiled: Navigating the Complexities of Orthopedics, STELARA, Tariffs, and Oncology Growth in 2025
Jul 16,2025 03:41
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
JNJ has released its 2025 Q3 earnings. EPS was reported at 2.8, versus the expected 2.76, beating expectations. The chart below visualizes how JNJ has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
JNJ has released its 2025 Q3 earnings report, with revenue of 23.99B, reflecting a YoY change of 6.77%, and net profit of 5.15B, showing a YoY change of 91.24%. The Sankey diagram below clearly presents JNJ's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
